Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China
· Delayed Price · Currency is CNY 54.95
+1.65 (3.10%)
Apr 29, 2026, 3:00 PM CST
SHA:688091 Revenue
Shanghai Yizhong Pharmaceutical had revenue of 79.16M CNY in the quarter ending March 31, 2026, with 11.44% growth. This brings the company's revenue in the last twelve months to 325.20M, up 84.92% year-over-year. In the year 2025, Shanghai Yizhong Pharmaceutical had annual revenue of 317.08M with 82.72% growth.
Revenue (ttm)
325.20M
Revenue Growth
+84.92%
P/S Ratio
33.67
Revenue / Employee
867.21K
Employees
415
Market Cap
10.95B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yantai Dongcheng Pharmaceutical Group | 2.74B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Mayinglong Pharmaceutical Group | 3.91B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| Porton Pharma Solutions | 3.50B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 4.94B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |